The landmark 2017 Cell study (Baar MP et al., PMID: 28340339) demonstrated that: (1) FOXO4 protein specifically accumulates in senescent cells where it binds to p53 and prevents p53 from triggering apoptosis (this is the specific mechanism being targeted)
using a consistent, standardised solvent reduces inter-experiment variability Compatibility Compatible with all OL Research lyophilised peptide compounds
Due to its chemical structure, it is classified as an amino acid
These frameworks ensure the safety, purity, and consistency of BWFI, which directly impacts the integrity and validity of scientific experiments
Typical Treatment Timeline First 12 Months Hair shedding may stabilize Hair growth cycle begins transitioning 34 Months Early improvements in thickness and density Reduced shedding 6 Months Noticeably fuller-looking hair for many patients 912 Months Continued improvement with consistent use Individual results vary and depend on factors such as age, genetics, hormone levels, nutrition, and treatment adherence
There is no standard clinical guidance for cycling the stack because human trial data is minimal
